Biography and Research Information
OverviewAI-generated summary
Charlie Wright's research focuses on medication management and its impact on patient care, particularly within the context of neurological disorders and aging populations. Wright has published on the importance of medication reconciliation for patients with Parkinson's disease, highlighting potential challenges and best practices. Their work also extends to fundamental molecular mechanisms, with publications addressing dysregulated signaling pathways in osteosarcoma and the analysis of gene expression programs in neuroblastoma. These diverse publications indicate an interest in both clinical applications of pharmacology and the underlying biological processes of disease.
Metrics
- Publications: 3
Selected Publications
-
The Importance of Medication Reconciliation in a Patient with Parkinson’s Disease (2025)
Collaboration Network
Top Collaborators
Richard H. Chapple
St. Jude Children's Research Hospital (US)
1 shared publication
- Abstract 4075: Meta-analysis of neuroblastoma single cell RNA-seq datasets identifies conserved and divergent gene expression programs across human and preclinical models
Min Pan
St. Jude Children's Research Hospital (US)
1 shared publication
- Abstract 4075: Meta-analysis of neuroblastoma single cell RNA-seq datasets identifies conserved and divergent gene expression programs across human and preclinical models
Paul Geeleher
St. Jude Children's Research Hospital (US)
1 shared publication
- Abstract 4075: Meta-analysis of neuroblastoma single cell RNA-seq datasets identifies conserved and divergent gene expression programs across human and preclinical models
Ian Delahunty
St. Jude Children's Research Hospital (US)
1 shared publication
- Abstract B043: Dysregulated AKT signaling reprograms osteosarcoma to drive selective reliance on EP300
Stephanie Nance
St. Jude Children's Research Hospital (US)
1 shared publication
- Abstract B043: Dysregulated AKT signaling reprograms osteosarcoma to drive selective reliance on EP300
Yang Zhang
St. Jude Children's Research Hospital (US)
1 shared publication
- Abstract B043: Dysregulated AKT signaling reprograms osteosarcoma to drive selective reliance on EP300
François Lamoureux
Nantes Université (FR)
1 shared publication
- Abstract B043: Dysregulated AKT signaling reprograms osteosarcoma to drive selective reliance on EP300
Qi Liu
Dana-Farber Cancer Institute (US)
1 shared publication
- Abstract B043: Dysregulated AKT signaling reprograms osteosarcoma to drive selective reliance on EP300
Noha A.M. Shendy
St. Jude Children's Research Hospital (US)
1 shared publication
- Abstract B043: Dysregulated AKT signaling reprograms osteosarcoma to drive selective reliance on EP300
Sandra Kietlinska
St. Jude Children's Research Hospital (US)
1 shared publication
- Abstract B043: Dysregulated AKT signaling reprograms osteosarcoma to drive selective reliance on EP300
Barbara De Kegel
Broad Institute (US)
1 shared publication
- Abstract B043: Dysregulated AKT signaling reprograms osteosarcoma to drive selective reliance on EP300
Matthew G. Rees
Broad Institute (US)
1 shared publication
- Abstract B043: Dysregulated AKT signaling reprograms osteosarcoma to drive selective reliance on EP300
Anoop Kavirayani
St. Jude Children's Research Hospital (US)
1 shared publication
- Abstract B043: Dysregulated AKT signaling reprograms osteosarcoma to drive selective reliance on EP300
Paris Prinsen
St. Jude Children's Research Hospital (US)
1 shared publication
- Abstract B043: Dysregulated AKT signaling reprograms osteosarcoma to drive selective reliance on EP300
Yousef Khashana
St. Jude Children's Research Hospital (US)
1 shared publication
- Abstract B043: Dysregulated AKT signaling reprograms osteosarcoma to drive selective reliance on EP300
Similar Researchers
Based on overlapping research topics
S. Ly
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Meta-analysis and systematic reviews
Healthcare Policy and Management
Weston Northington
Hendrix College
Pharmacological Effects and Toxicity Studies
Cancer-related molecular mechanisms research
Molecular Biology Techniques and Applications
Rohit Dhall
University of Arkansas for Medical Sciences
Parkinson's Disease Mechanisms and Treatments
Pharmacological Effects and Toxicity Studies
Healthcare Policy and Management
M.D.Ph.D. Stephan B Melnyk
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Cancer-related molecular mechanisms research
Molecular Biology Techniques and Applications
Natalie Guley
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Meta-analysis and systematic reviews
Neurological disorders and treatments
William J. Shelton
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Meta-analysis and systematic reviews
Neurological disorders and treatments